Rapid Dose Therapeutics Corp — Investor Relations & Filings
Rapid Dose Therapeutics Corp. is a pharma-technology company specializing in proprietary drug delivery technologies engineered to enhance patient outcomes and quality of life. The core business revolves around an innovative oral delivery platform utilizing sublingual thin film strip technology. The company's flagship product, QuickStrip™, is a fast-dissolving system designed for the rapid release of pharmaceuticals, micronized oils, and over-the-counter medicines. QuickStrip™ is distinguished by its ability to achieve blood concentrations comparable to intravenous injection, offering superior bioavailability and rapid onset. RDT provides product innovation, production, and consultation services to the pharmaceutical and healthcare manufacturing sectors for both prescription and non-prescription applications.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2021-09-15 | English | |
| Certificate re dissemination to shareholders.pdf | 2021-08-27 | English | |
| Other.pdf | 2021-08-27 | English | |
| News release - English.pdf | 2021-08-25 | English | |
| News release - English.pdf | 2021-08-25 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2021-08-25 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
15 filings
| |||||
| 22084965 | News release - English.pdf | 2021-09-15 | English | ||
| 21919434 | Certificate re dissemination to shareholders.pdf | 2021-08-27 | English | ||
| 47389122 | Other.pdf | 2021-08-27 | English | ||
| 47389138 | News release - English.pdf | 2021-08-25 | English | ||
| 47389142 | News release - English.pdf | 2021-08-25 | English | ||
| 47389146 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2021-08-25 | English | ||
| 47389375 | Interim MD&A - English.pdf | 2021-08-25 | English | ||
| 47389380 | Interim financial statements/report – English.pdf | 2021-08-25 | English | ||
| 47389385 | 52-109FV1 - Certification of annual filings - CFO (E).pdf | 2021-08-25 | English | ||
| 47389419 | Annual MD&A - English.pdf | 2021-08-25 | English | ||
| 47389424 | Audited annual financial statements – English.pdf | 2021-08-25 | English | ||
| 13527851 | News release - English.pdf | 2021-08-11 | English | ||
| 13526190 | News release - English.pdf | 2021-07-30 | English | ||
| 13524409 | News release - English.pdf | 2021-07-28 | English | ||
| 13524396 | News release - English.pdf | 2021-07-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Rapid Dose Therapeutics Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46464/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46464 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46464 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46464 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46464}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Rapid Dose Therapeutics Corp (id: 46464)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.